Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1221 (LINC01221)

Target
LINC01221
Molecular classification
Long non-coding RNA (lncRNA), Non-coding transcript
01

Overview

Long intergenic non-protein coding RNA 1221 (LINC01221) is a human long non-coding RNA gene, located at chromosome 1q32, that does not encode a protein but regulates gene expression at the transcriptional and post-transcriptional levels. LINC01221 has been identified as significantly overexpressed in pediatric T-cell acute lymphoblastic leukemia (T-ALL), where it may contribute to disease progression through modulation of apoptosis, cell proliferation, metastasis, and cancer survival pathways. LINC01221 and related lncRNAs are being studied for their role in cancer pathogenesis and their potential as biomarkers for diagnosis, prognosis, and disease subtype discrimination in leukemia. Although computational enrichment analyses suggest possible interactions with anticancer therapeutics, no direct drug targeting has yet been validated.

Other names
TCONS_00000366LINC01221
02

Mechanism of action

Not a direct drug target; mechanisms of drugs interacting with LINC01221, if any, are currently unknown due to its non-coding RNA nature. Any effects are likely mediated through modulation of gene expression and cellular pathways involved in apoptosis, proliferation, or drug response.

03

Biological functions

Gene expression regulationCell proliferationApoptosis (programmed cell death)MetastasisCancer pathogenesis
04

Disease associations

Cancer (primarily leukemia, especially T-cell acute lymphoblastic leukemia (T-ALL))
05

Safety considerations

No specific safety concerns are known. As an endogenous non-coding RNA, the main therapeutic challenge lies in delivery and specificity of targeting if anti-lncRNA therapeutics are considered.
06

Interacting drugs

Paclitaxel

2 more in the full profile.

07

Biomarkers

Lineage-specific biomarker for T-cell acute lymphoblastic leukemia (T-ALL)Potential diagnostic and prognostic utility in hematologic malignancies

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1221 (LINC01221).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1221 (LINC01221).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call